$EW

Edwards Lifesciences Corporation

  • NEW YORK STOCK EXCHANGE, INC.
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

PRICE

$87.87 -

Extented Hours

VOLUME

3,128,902

DAY RANGE

86.84 - 88.15

52 WEEK

52.41 - 91.23

Echofin Members Consensus

profile
Marcosx #ivtrades Join team
recently

$QS up good since Chris mention ew days ago

profile
Pal #droscrew Join team
recently

$PLTR downgraded by Morgan Stanley from EW to UW with $17PT

profile
Pal #droscrew Join team
recently

$TSLA raised from EW to OW at Morgan Stanley. PT raised from $360 to $540

CO
Coolmakina #FOREX Join team
recently

EW, too difficult to my brain

HE
HeyShoe #droscrew Join team
recently

cybercash endorses $EW

BE
Benlax #droscrew Join team
recently

$EW one to keep an eye on beat and raise but for some reason sold off

profile
thegiz18 #ivtrades Join team
recently

$TSLA, $CMG, $LVS, $WHR, $XLNX, ALGN, $EW some of the earnings for tonight

profile
zonatrading #Zona Trading Join team
recently

$EW muy interesante para esta semana si el mercado recupera tendencia.

BE
Benlax #droscrew Join team
recently

medical equipment strong $NVCR $VAPO $EW $ISRG

profile
QuaidDC #droscrew Join team
recently

Here's an EW roadmap that might be worth a read:

profile
dros #droscrew Join team
recently

nice $EW trade ben

BE
Benlax #droscrew Join team
recently

out $EW 3.1 to 8.7

profile
Andyyy #tradewithandy Join team
recently

Last bottom was 1670. Top was 2075 1860 bottom + 405 = 2265. In range of our 2250 top. This is a massive AB=CD pattern Sept 21 would be just over 4 weeks which is reasonable We will partial tp at 2150 area and short hedge the rest on the first 2xh4 bearish candle i got 2250 without EW or AB=CD, close enough to 2260 definitely safe to short at 2250-2260, and sl at the end of that daily

profile
dros #droscrew Join team
recently

that’s really OTM on EW..got a few resistances to take out first

profile
dros #droscrew Join team
recently

$EW 18SEP20 $85 Cs // 2k+ trading vs 269 OI

profile
dros #droscrew Join team
recently

$EW 18SEP20 $85 Cs // 2k+ trading vs 269 OI

BE
Benlax #droscrew Join team
recently

$EW sept 85c very active today

BE
Benlax #droscrew Join team
recently

$EW getting tight

profile
Pal #droscrew Join team
recently

$TSLA upgraded to EW from UW at Morgan Stanley

BE
Benlax #droscrew Join team
recently

ew i just went to farfetchs site

BE
Benlax #droscrew Join team
recently

$EW post beat and raise ER

profile
dros #droscrew Join team
recently

gotta agree with him/her on $EW

BE
Benlax #droscrew Join team
recently

black watch with black face on pale kid = ew

profile
lucullus #droscrew Join team
recently

yes in fact SPXEW equal weight s&P was up slightly yesterday...it was momo as you say. It has only happened 1 othet time in last 20 years S&P down >1% and EW positive

HE
HeyShoe #droscrew Join team
recently

$INTC, $EW, $SIVB, $SWKS, $SAM

profile
dros #droscrew Join team
recently

$EW got that nice beat

BE
Benlax #droscrew Join team
recently

EW with a beat and raise

BE
Benlax #droscrew Join team
recently

beat and raise for $EW

BE
Benlax #droscrew Join team
recently

bsx isrg mdt ew etc.

BE
Benlax #droscrew Join team
recently

ew nasty reversal $CPRI

Key Metrics

Market Cap

54.76 B

Beta

0.97

Avg. Volume

2.24 M

Shares Outstanding

623.25 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

CEO: Michael Mussallem

Website:

HQ: 1 Edwards Way Irvine, 92614-5688 California

Related News

  • Stocks News Feed

    Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021 - Stocks News Feed

    13 Jan 2021, 12:05
  • OpenPR

    Prosthetic Heart Valves Market Emerging Technology, Growth And Key Players Insights and Growing Demand | Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation

    13 Jan 2021, 07:37
  • OpenPR

    Transcatheter Aortic Valve Replacement Market to Witness Huge Growth by 2024| Key Players are Edwards Lifesciences, Boston Scientific, Medtronic, Abbott, Venus Medtech and JenaValve Technology

    11 Jan 2021, 14:18
  • PR Newswire

    Global Central Venous Catheters Market Analysis and Forecast to 2030 Featuring Teleflex, CR Bard, Edwards Lifesciences, Vygon, B. Braun Melsungen, Smiths Medical & Kimal

    08 Jan 2021, 19:30
  • Benzinga

    The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica

    29 Dec 2020, 13:09